Company Filing History:
Years Active: 2025
Title: Ferda Cevikbas: Innovator in Inflammatory Disorder Treatments
Introduction
Ferda Cevikbas is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of inflammatory disorders. His innovative work has the potential to improve the quality of life for many individuals suffering from these conditions.
Latest Patents
Cevikbas holds a patent for "MrgprX2 antagonists for the treatment of inflammatory disorders." This patent focuses on the use of MrgprX2 antagonists in treating inflammatory disorders, including those affecting the skin. The invention also encompasses pharmaceutical compositions that combine a MrgprX2 antagonist with a pharmaceutically acceptable carrier for effective administration. He has 1 patent to his name.
Career Highlights
Ferda Cevikbas is currently associated with Dermira, Inc., a company dedicated to developing innovative therapies for dermatological conditions. His work at Dermira has positioned him as a key player in the pharmaceutical industry, particularly in the realm of skin-related inflammatory disorders.
Collaborations
Cevikbas collaborates with talented professionals in his field, including Ashley Jarvis and Laura Gleave. These collaborations enhance the research and development efforts at Dermira, fostering an environment of innovation and progress.
Conclusion
Ferda Cevikbas is a distinguished inventor whose work in the treatment of inflammatory disorders showcases his commitment to advancing medical science. His contributions through patents and collaborations continue to pave the way for new therapeutic options.